Conjugated linoleic acid and black currant seed oil in the treatment of canine atopic dermatitis: a preliminary report.
Although conjugated linoleic acid (CLA) shows inhibitory effects on histamine release, eicosanoid production and pruritus in laboratory rodents, its use in canine atopic dermatitis (AD) has not been reported. The aims of this study were to assess the efficacy of CLA, black currant seed oil (BSO) or a combination of both, compared to placebo, in dogs with AD and to evaluate any changes in fatty acid metabolism with these treatments. Twenty-four dogs with AD were randomly allocated to four groups, and were treated orally each day for two months with either 1 mL/10 kg CLA (80% purity), 1 mL/10 kg pure BSO, 1 mL/10 kg CLA+1 mL/10 kg BSO, or 1 mL/10 kg sugar syrup (placebo). Serum was obtained on days 0, 30 and 60 for analysis of CLA metabolites, linoleic acid (LA), gamma-linolenic acid (GLA), dihomo-gamma-linolenic acid (DGLA) and arachidonic acid (AA). At the same time point, the owners were asked to assess pruritus and the veterinarians evaluated any skin lesions present. Although the best clinical results occurred with BSO treatment alone, improvement of clinical signs and pruritus was not significant with any of the treatments. Serum levels of GLA and DGLA significantly increased in BSO-treated dogs, but not in the CLA+BSO group. CLA at the dosage used in this study was not efficacious in treating canine AD, whereas BSO may help some dogs with AD, although further studies are necessary before this can be recommended as a treatment.
Noli
C
C
Ospedale Veterinario Cuneese, Via Cuneo 52/N, 12011 Borgo San Dalmazzo (CN), Italy. pitnoli@iol.it
Carta
G
G
Cordeddu
L
L
Melis
M P
MP
Murru
E
E
Banni
S
S
D000818:Animals; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000662:veterinary*; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D044243:Linoleic Acids, Conjugated / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D016896:Treatment Outcome; D017965:gamma-Linolenic Acid / Q000008:administration & dosage* / Q000627:therapeutic use
D044243:Linoleic Acids, Conjugated; D017965:gamma-Linolenic Acid; C084865:black currant oil